Nureca Ltd (NURECA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543264 | NSE: NURECA | Medical Equipment/Supplies/Accessories | Small Cap

Nureca Ltd. Share Price

305.05 -0.45 -0.15%
as on 05-Dec'25 15:40

Nureca Ltd (NURECA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543264 | NSE: NURECA | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on Nureca Ltd.

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Nureca stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
123.44
Market Cap:
305.5 Cr.
52-wk low:
198
52-wk high:
447

Is Nureca Ltd an attractive stock to invest in?

1. Is Nureca Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nureca Ltd is a average quality company.

2. Is Nureca Ltd undervalued or overvalued?

The key valuation ratios of Nureca Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Nureca Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Nureca Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Nureca Ltd.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nureca Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%103.9%92.4%76%67.7%33.6%-5.3%-1.5%0.3%-
Value Creation
Index
NANA6.45.64.43.81.4-1.4-1.1-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000.60.799.421325611294.5115131
Sales YoY Gr.-NANA23.7%13,520.6%114.6%19.8%-56.2%-15.5%21.3%-
Adj EPS 002.22.8911.646.644.7-10.1-2.8-0.82.5
YoY Gr.-NANA26.5%32226.6%-94.9%-4.1%-122.5%NANA-
BVPS (₹) 003.36.41,995.7163.3203.7195.3192.9192.5196.2
Adj Net
Profit
00006.446.644.7-10.1-2.8-0.82
Cash Flow from Ops. 0000.1-7.935.11.812.1-3-18.6-
Debt/CF from Ops. 0000-1.200.60-0.1-0.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA2.9%-23.5%21.3%
Adj EPS NA-124.7%-126.5%NA
BVPSNA-37.4%-1.9%-0.2%
Share Price - - -16.1% 4.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0060.454.48552.324.4-5.1-1.4-0.41.3
Op. Profit
Mgn %
0044.29.829.422.1-13.5-11.8-8.5-2
Net Profit
Mgn %
002.72.76.421.917.5-9-2.9-0.71.9
Debt to
Equity
00000.7000000
Working Cap
Days
0003606083130291204283238
Cash Conv.
Cycle
00010439385814110186221

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.30%

Sales growth is good in last 4 quarters at 37.02%

Sales growth has been subdued in last 3 years -23.45%

Net Profit has been subdued in last 3 years -126.48%

Latest Financials - Nureca Ltd.

Standalone Consolidated
TTM EPS (₹) 2.5 4.1
TTM Sales (₹ Cr.) 131 130
BVPS (₹.) 196.2 198.7
Reserves (₹ Cr.) 186 189
P/BV 1.56 1.54
PE 123.44 74.39
From the Market
52 Week Low / High (₹) 198.00 / 447.00
All Time Low / High (₹) 198.00 / 2316.60
Market Cap (₹ Cr.) 306
Equity (₹ Cr.) 10
Face Value (₹) 10
Industry PE 53.3

Management X-Ray of Nureca Ltd.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Nureca Ltd. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Nureca Ltd.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales119921325611295115
Operating Expenses 1190152200127106125
Manufacturing Costs000142100
Material Costs016599133786780
Employee Cost 003510161214
Other Costs 00223456332730
Operating Profit 00106256-15-11-10
Operating Profit Margin (%) 4.0%4.2%9.8%28.9%21.8%-13.8%-11.8%-8.7%
Other Income 0003871113
Interest 00121001
Depreciation 00001222
Exceptional Items 00000000
Profit Before Tax 0096261-11-3-0
Tax 0021616-3-10
Profit After Tax 0064745-8-2-1
PAT Margin (%) 2.7%2.8%6.4%21.8%17.7%-7.5%-2.6%-0.6%
Adjusted EPS (₹)2.23.0915.746.545.3-8.4-2.4-0.7
Dividend Payout Ratio (%)0%0%0%4%7%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0014163204195193192
Share Capital 0001010101010
Reserves 0014153194185183182
Minority Interest00000000
Debt00910001
Long Term Debt00910001
Short Term Debt00000000
Trade Payables01695556
Others Liabilities 0052744424
Total Liabilities 0134200252204200203

Fixed Assets

Gross Block00141110913
Accumulated Depreciation00002235
Net Fixed Assets 001310868
CWIP 00000000
Investments 00013462974
Inventories01163763332936
Trade Receivables001303425
Cash Equivalents flag 00012684714546
Others Assets 00332582621105
Total Assets 0134200252204200203

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 00-835212-3-19
PBT 0096261-11-3-0
Adjustment 0010-4-4-7-8
Changes in Working Capital 00-18-12-38316-9
Tax Paid -0-0-0-15-18-41-1
Cash Flow From Investing Activity 0-0-0-110-3-18189
Capex 0-0-0-0-6-0-0-2
Net Investments 000-109-1-1798
Others 000-14-193
Cash Flow From Financing Activity 00892-7-2-1-1
Net Proceeds from Shares 0001050000
Net Proceeds from Borrowing 00-1-13-1001
Interest Paid 00-1-1-0-0-0-1
Dividend Paid 0000-5000
Others 0091-1-1-1-1
Net Cash Flow 00-017-9-814-11

Finance Ratio

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/A91.4852.524.69-4.22-1.26-0.35
ROCE (%)N/AN/A7667.7433.61-5.26-1.450.34
Asset Turnover Ratio1.750.95.891.921.190.510.510.63
PAT to CFO Conversion(x)N/AN/A-1.330.740.04N/AN/AN/A
Working Capital Days
Receivable Days87682311211119
Inventory Days8024130436815011092
Payable Days231529202719232724

Nureca Ltd Stock News

Nureca Ltd FAQs

The current trading price of Nureca Ltd. on 05-Dec-2025 15:40 is ₹305.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Nureca Ltd. stood at ₹305.5.
The latest P/E ratio of Nureca Ltd. as of 04-Dec-2025 is 123.4.
The latest P/B ratio of Nureca Ltd. as of 04-Dec-2025 is 1.56.
The 52-week high of Nureca Ltd. is ₹447.0 and the 52-week low is ₹198.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nureca Ltd. is ₹131.1 ( Cr.) .

About Nureca Ltd

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. 

The company has most of the product lines supporting home health market in India, making it a one-stop solution provider. Dr Trust is a known for its innovative products in the market, and, with the segment showing significant potential for growth, the company is positioned to show significant growth.

The company has a diversified product portfolio, which primarily caters to home healthcare sector. It provides an improved product mix to its customers and their preferences thereby targeting a wider customer base. Its growth is further driven by its ability to make available an assortment of quality products under trusted brands built by the company.

Products:

Currently, the company classify its products portfolio under the following five categories such as:

  • Chronic Device Products - which includes products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self monitoring glucose devices, humidifier and steamers.
  • Orthopedic Products - which includes rehabilitation products such as wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers.
    Mother and Child Products - which includes products such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carry cots.
  • Nutrition Supplements - which includes products such as fish oil, multivitamins, probiotics, botin, apple cider and vinegar.
  • Lifestyle Products - which includes products such as smart scales, aroma diffusers and fitness tracker.

Key awards, recognitions and accreditations

  • 2020: The company received ISO 9001:2015 Certificate of Registration from Intertek Certification Limited for Management System, which is applicable to sales, services and warehousing of medical devices, consumer electronics, pharmaceutical and personal care products.
  • 2020: Appreciation Letter from Pharmaceuticals Export Promoter Council of India stating the company as a very dynamic and evolving medical devices company and has created a credible and leading brand ‘Dr. Trust’ which is now a household name in India.

Major events and milestones:

  • 2016: Online launch of Dr. Trust Brand.
  • 2017: Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.
  • 2017: Started three flex centres in Punjab, Karnataka and Uttar Pradesh.
  • 2018: The company became the wholly owned subsidiary of Nectar Biopharma Private Limited.
  • 2018: Added three flex centres in Chandigarh, Telangana and Maharashtra.
  • 2018: Secured warehouse drug license.
  • 2020 Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the company pursuant to the Scheme of Arrangement.
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×